Skip to Content
MilliporeSigma
All Photos(1)

Key Documents

58985C30

Supelco

SUPELCOSIL LC-18 (3 µm) HPLC Columns

L × I.D. 15 cm × 3 mm, HPLC Column

Sign Into View Organizational & Contract Pricing


About This Item

UNSPSC Code:
41115700
eCl@ss:
32110501
NACRES:
SB.52

Pricing and availability is not currently available.

Product Name

SUPELCOSIL LC-18 HPLC Column, 3 μm particle size, L × I.D. 15 cm × 3 mm

material

stainless steel column

Quality Level

agency

suitable for USP L1

product line

SUPELCOSIL

feature

endcapped

manufacturer/tradename

SUPELCOSIL

packaging

1 ea of

extent of labeling

11.0% carbon loading

parameter

≤70 °C temp. limit
400 bar pressure (5801 psi)

Looking for similar products? Visit Product Comparison Guide

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
58984C4058230C3058230C40
L × I.D.

15 cm × 3 mm

L × I.D.

7.5 cm × 4 mm

L × I.D.

15 cm × 3 mm

L × I.D.

15 cm × 4 mm

particle size

3 μm

particle size

3 μm

particle size

5 μm

particle size

5 μm

matrix active group

C18 (octadecyl) phase

matrix active group

C18 (octadecyl) phase

matrix active group

C18 (octadecyl) phase

matrix active group

C18 (octadecyl) phase

separation technique

reversed phase

separation technique

reversed phase

separation technique

reversed phase

separation technique

reversed phase

agency

suitable for USP L1

agency

suitable for USP L1

agency

suitable for USP L1

agency

suitable for USP L1

pore size

120 Å

pore size

120 Å

pore size

120 Å

pore size

120 Å

General description

A general purpose hydrophobic alkyl phase that is very retentive and gives good peak shape for a wide variety of compounds.

Recommended products

Discover LiChropur reagents ideal for HPLC or LC-MS analysis

Legal Information

SUPELCOSIL is a trademark of Sigma-Aldrich Co. LLC

  • Choose from one of the most recent versions:

    Certificates of Analysis (COA)

    Lot/Batch Number

    Don't see the Right Version?

    If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

    Already Own This Product?

    Find documentation for the products that you have recently purchased in the Document Library.

    Visit the Document Library

    Matthew H Crouthamel et al.
    Arteriosclerosis, thrombosis, and vascular biology, 33(11), 2625-2632 (2013-08-24)
    Elevated serum phosphate has emerged as a major risk factor for vascular calcification. The sodium-dependent phosphate cotransporter, PiT-1, was previously shown to be required for phosphate-induced osteogenic differentiation and calcification of cultured human vascular smooth muscle cells (VSMCs), but its
    Matthew R Weir et al.
    Journal of clinical hypertension (Greenwich, Conn.), 16(12), 875-882 (2014-10-21)
    The effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on blood pressure (BP) and osmotic diuresis- and intravascular volume reduction-related adverse events (AEs) were evaluated using pooled data from four placebo-controlled, phase 3 studies in patients with type 2
    Luciano Candilio et al.
    Heart (British Cardiac Society), 101(3), 185-192 (2014-09-26)
    Remote ischaemic preconditioning (RIPC), using brief cycles of limb ischaemia/reperfusion, is a non-invasive, low-cost intervention that may reduce perioperative myocardial injury (PMI) in patients undergoing cardiac surgery. We investigated whether RIPC can also improve short-term clinical outcomes. One hundred and
    George G S Sandor et al.
    International journal of cardiology, 179, 470-475 (2014-12-04)
    Patients with Marfan (MFS) and Loeys-Dietz (LDS) syndromes have been shown to have abnormal aortic biophysical properties. The purpose of this study was to compare the effects of 12-months of therapy with atenolol or losartan on vascular function in young
    Karen Sliwa et al.
    Heart (British Cardiac Society), 100(24), 1967-1974 (2014-09-18)
    Lack of evidence-based data on the spectrum of cardiovascular disease (CVD) in pregnancy or in the postpartum period, as well as on maternal and fetal outcome, provides challenges for treating physicians, particularly in areas of low resources. The objectives of

    Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

    Contact Technical Service